Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1β in Vascular Smooth Muscle Cells
Open Access
- 1 August 1998
- journal article
- Published by Elsevier
- Vol. 273 (32) , 20341-20346
- https://doi.org/10.1074/jbc.273.32.20341
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.Genes & Development, 1997
- Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.Journal of Clinical Investigation, 1996
- Reciprocal induction of tumor necrosis factor-? and interleukin-? activity mediates fibronectin synthesis in coronary artery smooth muscle cellsJournal of Cellular Physiology, 1995
- Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferationAtherosclerosis, 1993
- LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 ReleaseScience, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988
- γ-Interferon is one of several direct B cell-maturing lymphokinesNature, 1984
- Role of γ-interferon in antibody-producing responsesNature, 1984
- Functional angiotensin II receptors in cultured vascular smooth muscle cells.The Journal of cell biology, 1982